The abstract is read at the publisher; the summary is JClub's.
Bilateral GPi-DBS in children and young adults with genetically confirmed GNAO1-related disorder reduced dyskinetic crisis burden in 38 of 40 patients (95%) over 4.5 ± 3.7 years.
- Why it matters: The disorder’s life-threatening dyskinetic crises create major morbidity, yet the best timing, selection, and long-term clinical impact of bilateral GPi-DBS in GNAO1 remained uncertain.
- What they did: In a retrospective multicenter cohort across 17 centers using the DBSMatchMaker platform, 46 patients (mean age 10.4 ± 4.8 years) received bilateral GPi-DBS, with outcomes including crisis burden, BFMDRS, CGI, medication burden, and complications.
- The result: Dyskinetic crises were reduced and ICU admissions fell by 86.1%, while BFMDRS motor scores improved by 27.5% (p < 0.001, Cohen’s d = 1.12) and CGI improved in 93.5%, with complications in 19.6% mainly among emergent implants.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.